Inventor · disambiguated record
Diane Van Hoorick
Also filed as: VAN HOORICK DIANE
12 granted patents·10 pending applications·44 citations·filing 2010–2025
89Inventor score
Top patents by PatentIndex Score
22 records- 0193US10927186B2T cell recruiting polypeptides based on TCR alpha/beta reactivityABLYNX NV·Filed 2016·Granted Feb 23, 2021·19 cites·20 claims
- 0288US11384151B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2019·Granted Jul 12, 2022·2 cites·11 claims
- 0387US11932702B2Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptorABLYNX NV·Filed 2021·Granted Mar 19, 2024·3 cites·28 claims
- 0487US11046767B2T cell recruiting polypeptides based on CD3 reactivityABLYNX NV·Filed 2016·Granted Jun 29, 2021·5 cites·17 claims
- 0586US9035029B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsSINGH SANJAYA·Filed 2013·Granted May 19, 2015·7 cites·36 claims
- 0685US10385134B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 20, 2019·3 cites·18 claims
- 0782US12221487B2Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2022·Granted Feb 11, 2025·0 cites·20 claims
- 0881US9783612B2CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 10, 2017·2 cites·12 claims
- 0980US9458235B2Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Oct 4, 2016·2 cites·2 claims
- 1076US2025388672A1T cell recruiting polypeptides based on cd3 reactivityABLYNX NV·Filed 2025·Application pending·0 cites
- 1174US11840569B2T cell recruiting polypeptides capable of binding CD123 and TCR alpha/betaABLYNX NV·Filed 2017·Granted Dec 12, 2023·1 cites·16 claims
- 1271US2024199740A1T cell recruiting polypeptides capable of binding cd123 and tcr alpha/betaABLYNX NV·Filed 2023·Application pending·0 cites
- 1368US12371496B2T cell recruiting polypeptides based on CD3 reactivityABLYNX NV·Filed 2021·Granted Jul 29, 2025·0 cites·19 claims
- 1466US2024343823A1Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptorABLYNX NV·Filed 2024·Application pending·0 cites
- 1563US2024109965A1Immunoglobulin single variable domains targeting t cell receptorABLYNX NV·Filed 2023·Application pending·0 cites
- 1659US2021395398A1T cell recruiting polypeptides based on tcr alpha/beta reactivityABLYNX NV·Filed 2020·Application pending·0 cites
- 1757US2024092919A1T cell recruiting polypeptides based on tcr alpha/beta reactivityABLYNX NV·Filed 2021·Application pending·0 cites
- 1848US2023071518A1INTRANASAL mRNA VACCINESETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 1947US2014120095A1Bispecific binding molecules for anti-angiogenesis therapyBORGES ERIC·Filed 2013·Application pending·0 cites
- 2042US2011172398A1Bispecific binding molecules for anti-angiogenesis therapyBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2135US2011195494A1Dll4-binging moleculesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2232US11149086B2KV1.3 binding immunoglobulinsABLYNX NV·Filed 2015·Granted Oct 19, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Diane Van Hoorick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →